Morris Richard Steven 4
4 · Carisma Therapeutics Inc. · Filed Feb 2, 2024
Insider Transaction Report
Form 4
Morris Richard Steven
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-01-31+170,500→ 170,500 totalExercise: $2.10Exp: 2034-01-31→ Common Stock (170,500 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest over four years in equal monthly installments, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date.